Acology Continues Strong Pace, Highlights of 10Q in Letter to Shareholders

CORONA, Calif., May 15, 2017 -- A Letter from CEO Curt Fairbrother

Dear Shareholders:

With Friday’s release of our 10Q our company’s health and strength continues to be decisively displayed along with the determination and commitment that have made the last 8 months the strongest of our existence. (OTC:ACOL)

The facts are simple; we’ve seriously reduced our operational and advertising costs while continuing to grow. Net profits have increased YOY and the explosive growth in our first quarter continues unabated. 2017 will set new records for profitability. Our debt continues to diminish and no new loans have been received and none are contemplated. Sales of new products now account for 25% of total revenue and are growing month to month. In short, the state of Acology’s health is thriving.

In answer to the many inquiries that we receive from our stockholders about our plans for enhancing our national and international marketing profile, we are now confident that we can increase spending and continue to improve our global position. In addition, our revenue pace continues to out-perform our expectations, our production capacity continues to easily handle our growth and our inventory levels are good.

Acquisition talks with EZ Health Solutions, including the ownership of intellectual properties, continues and our preparations to create a new CBD-Infused Health Products Division has gained momentum. There has been tremendous interest in the market about our plans to expand. Needless to say, we are very excited about our current situation and very positive about the future.

Those of you who have been with us for a while know that we’ve had remarkable success with our endeavors and have sustained us as we continued to grow and evolve. Thank you, as always, for your constant confidence and support.

Curt Fairbrother, CEO

For investor or sales information please visit Acology Inc. and D&C Distributors online or by phone. The company is located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880.

Acology trades on the OTC under the call letters ACOL. The company’s websites are www.Acologyinc.com for the hospice and palliative care industry and www.themedtainer.com for the recreational and medical marijuana industry. Orders for Acology products can be taken online and by phone. Custom orders are especially welcome.  Please send all inquiries to [email protected] or call (844) ACOLOGY (844-226-5649).  Acology can also be accessed through Twitter and Instagram at @Acologyinc

This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events they are subject to risks and uncertainties and actual results for fiscal year 2016 and beyond could differ materially from the company’s current expectations. Forward-looking statements are identified by such words as “anticipates”, “projects”, “expects”, “planned”, “intends” and “believes” “estimate” “targets” and other similar expressions that indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in the loss of some or all his or her investment.